期刊文献+

降钙素原指导社区获得性肺炎抗菌治疗终止的应用研究 被引量:1

Research on procalcitonin-guided antibiotic treatment termination in community-acquired pneumonia
下载PDF
导出
摘要 目的通过对照研究利用血清降钙素原(Procalcitonin,PCT)水平判断社区获得性肺炎(community-acquired pneumonia,CAP)终止抗菌药物治疗的时机的可行性。方法 220例CAP住院患者随机分为两组:实验组140例,对照组80例。实验组在入院后24 h内采集静脉血清进行PCT检查,血清PCT>0.5 ng/ml者隔日进行采血检查,当PCT<0.5 ng/ml或者下降超过峰值的80%时停用抗菌药物;对照组则根据医生临床判断决定停用抗菌药物时机。结果共207例患者完成临床试验。实验组抗菌药物使用天数、住院天数明显低于对照组(6.7±1.3、7.2±1.4 vs 8.6±1.7、9.1±1.6),(P<0.05);实验组住院总费用明显低于对照组(4531±708.3 vs 6067±912.7),(P<0.05);两组肺炎复发率无差异(P>0.05)。结论 PCT是判断CAP抗菌治疗终止时机的良好指征,此方法具有临床可行性。 Objective To investigate the feasibility of serum procalcitonin( PCT) levels determining the timing of antibiotic therapy termination in patients with community-acquired pneumonia( CAP) by randomised controlled trial. Methods 220 inpatients with pneumonia were randomly divided into two groups: 140 patients in the experimental group and 80 patients in the control group. In the experimental group,serum PCT was detected within24 hours. If their serum PCT 0. 5ng /ml they were checked every other day for blood later. Antibiotic treatment were adviced to stop in case PCT decreased more than 80% of its peak level or decreased below a value of 0. 5 ng /ml. In the control group,antibiotics termination was according to clinical judgment of the doctors' decision. Results 207patients completed the clinical trials. The days of antibiotics and duration of hospitali stay in the experimental group were significantly lower in the experimental group than in the control grou p( 6. 7 ± 1. 3,7. 2 ± 1. 4 vs 8. 6 ± 1. 7,9. 1± 1. 6)( P 0. 05). The total cost of hospital stay in the experimental group was significantly lower than that in the control group( 4531 ± 708. 3 vs 6067 ± 912. 7)( P 0. 05). There was no significant difference in relapse rate of pneumonia between the two groups( P 0. 05). Conclusion PCT is a good indication to judge the timing of termination antibiotic therapy in CAP.
出处 《临床肺科杂志》 2014年第8期1366-1368,共3页 Journal of Clinical Pulmonary Medicine
基金 湖南省医药卫生科研计划课题项目(No B2008-045)
关键词 降钙素原 社区获得性肺炎 抗菌药物 community-acquired pneumonia antibiotics procalcitonin
  • 相关文献

参考文献6

  • 1廖瑾莉,黄文杰,袁伟锋,王丹.血清降钙素原、肾上腺髓质素与髓系细胞触发受体-1在肺炎诊断与病情判断上的价值[J].临床肺科杂志,2010,15(6):757-759. 被引量:32
  • 2Schuetz P,Müller B,Christ-Crain M,et al.Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections[J].Ann Intern Med,2013,158(4):JC5.
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 4Infectious Diseases Society of America/American Thoracic society.Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults[J].Clinical Infectious Diseases,2007,44:S27-S72.
  • 5Assink-de Jong E,de Lange DW,van Oers JA,et al.Stop Antibiotics on guidance of Procalcitonin Study(SAPS):a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients-calculated sample size:1816 patients[J].BMC Infect Dis,2013,16(13):178.
  • 6Jensen JU,Lundgren B,Hein L,et al.The Procalcitonin And Survival Study(PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels,can improve survival in intensive care unit patients.Calculated sample size(target population):1000 patients[J].BMC Infect Dis,2008,(13)8:91.

二级参考文献32

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2葛庆岗,阴赪宏,文艳,吕旌乔,王谊冰.血清降钙素原与多器官功能障碍综合征严重程度相关性的临床研究[J].中国危重病急救医学,2005,17(12):729-731. 被引量:28
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 4谢灿茂.肺部感染性疾病[M].见:陆再英,钟南山主编.内科学.第7版.北京:人民卫生出版社,2008.17-38.
  • 5Fine MJ,Anble TE,Yealy DM,et al.A predictation to identify lowrisk patients with community-acquired pneumonia[J].N Engl J Med,1997,336(4):243-250.
  • 6Hirakata Y,Yanagihara K,Kurihara S,et al.Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia[J].Diagn Microbiol Infeer Dis,2008,61(2):170-4 Epub 2008 Mar 7.
  • 7Schuetz P,Christ-Crain M,Morgenthaler NG,et al.Circulating precursor levels of endothelin-1 and adrenomedullin,two endothelium-derived,counteracting substances,in sepsis[J].Endothelium,2007,14(6):345-51.
  • 8Bouchon A,Facchetti F,Weigand MA,et al.TREM-1 amplifies inflammation and is a crucial mediator of septic shock[J].Nature,2001,410(6832):1103-1107.
  • 9Tejera A,Santolaria F,Diez ML,et al.Prognosis of community acquired pneumonia(CAP):value of triggering receptor expressed on myeloid cells-1(TREM-1)and other mediators of the inflammatory response[J].Cytokine,2007,38(3):117-123.
  • 10Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.

共引文献3084

同被引文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部